Evidence map›Paper›PMID 28599434›Full record

ArticleOncology letters2017

The role of microvessel density, lymph node metastasis, and tumor size as prognostic factors of distant metastasis in colorectal cancer.

Tomonari Cho, Eisuke Shiozawa, Fumihiko Urushibara, Nana Arai, Toshitaka Funaki, Yusuke Takehara, Sakiko Tazawa, Masashi Misawa, Mayumi Homma, Tomoko Norose and 8 more

Open access · diamondAbstract read
In one paragraph

Article in Oncology letters, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 25 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. CD105: tumor diagnosis, prognostic marker and future tumor therapeutic target.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2022
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 2 institutions in 1 country.

Tomonari ChoDepartment of Pathology and Laboratory Medicine, Showa University School of Medicine, Shinagawa-ku, Tokyo 142-8555, Japan.
Eisuke ShiozawaDepartment of Pathology and Laboratory Medicine, Showa University School of Medicine, Shinagawa-ku, Tokyo 142-8555, Japan.
Fumihiko UrushibaraDepartment of Pathology and Laboratory Medicine, Showa University School of Medicine, Shinagawa-ku, Tokyo 142-8555, Japan.
Nana AraiDepartment of Pathology and Laboratory Medicine, Showa University School of Medicine, Shinagawa-ku, Tokyo 142-8555, Japan.
Toshitaka FunakiDepartment of Pathology and Laboratory Medicine, Showa University School of Medicine, Shinagawa-ku, Tokyo 142-8555, Japan.
Yusuke TakeharaDepartment of Pathology and Laboratory Medicine, Showa University School of Medicine, Shinagawa-ku, Tokyo 142-8555, Japan.
Sakiko TazawaDepartment of Pathology and Laboratory Medicine, Showa University School of Medicine, Shinagawa-ku, Tokyo 142-8555, Japan.
Masashi MisawaDigestive Disease Center, Showa University Northern Yokohama Hospital, Tsuzuki-ku, Yokohama 224-8503, Japan.
Mayumi HommaDepartment of Pathology and Laboratory Medicine, Showa University School of Medicine, Shinagawa-ku, Tokyo 142-8555, Japan.
Tomoko NoroseDepartment of Pathology and Laboratory Medicine, Showa University School of Medicine, Shinagawa-ku, Tokyo 142-8555, Japan.
Mutsuko OmatsuDepartment of Clinico-Diagnostic Pathology, Showa University Northern Yokohama Hospital, Tsuzuki-ku, Yokohama 224-8503, Japan.
Hideyuki MiyachiDigestive Disease Center, Showa University Northern Yokohama Hospital, Tsuzuki-ku, Yokohama 224-8503, Japan.
Toshiko YamochiDepartment of Pathology and Laboratory Medicine, Showa University School of Medicine, Shinagawa-ku, Tokyo 142-8555, Japan.
Toshiaki KunimuraDepartment of Clinico-Diagnostic Pathology, Showa University Northern Yokohama Hospital, Tsuzuki-ku, Yokohama 224-8503, Japan.
Genshu TateDepartment of Pathology and Laboratory Medicine, Showa University School of Medicine, Shinagawa-ku, Tokyo 142-8555, Japan.
Fumio IshidaDigestive Disease Center, Showa University Northern Yokohama Hospital, Tsuzuki-ku, Yokohama 224-8503, Japan.
Shin-Ei KudoDigestive Disease Center, Showa University Northern Yokohama Hospital, Tsuzuki-ku, Yokohama 224-8503, Japan.
Masahumi TakimotoDepartment of Pathology and Laboratory Medicine, Showa University School of Medicine, Shinagawa-ku, Tokyo 142-8555, Japan.
Showa University · JPShowa University Northern Yokohama Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Angiogenesis is essential for tumor growth and metastasis. CD105 is reportedly a specific marker for tumor angiogenesis. It has been demonstrated that monoclonal antibodies to CD105 have high affinity for activated endothelial cells. A relationship between metastasis and microvessel density (MVD), as an indicator of neovascularization, has been identified in patients with colorectal cancer as shown by the presence of monoclonal antibodies to CD105. However, data on potentially confounding factors such as lymphatic and vascular infiltration and tumor size are lacking. We further investigated the relationship between MVD and distant metastasis, along with potentially confounding clinicopathological factors, to more precisely characterize this relationship. In this retrospective study, we analyzed colorectal cancer specimens surgically or endoscopically resected from January to September 2009. We defined MVD as the number of microvessels stained by monoclonal antibodies to CD105 per ×400 field. Selected clinicopathological factors were analyzed and stepwise multivariate logistic regression was performed to identify independent risk factors for distant metastasis. We analyzed 129 lesions. The median follow-up time was 34 months (range, 6-85 months) in patients with distant metastasis and 61 months (range, 60-86 months) in those without distant metastasis. At the time of resection or during subsequent follow-up, 32 patients had distant metastases. The MVD was significantly greater in patients with than without distant metastases (mean ± standard deviation: 10.4±4.9 vs. 7.6±3.3, P=0.008; Welch's t-test). Stepwise multivariate logistic regression indicated that MVD, regional lymph node metastasis, and tumor size were independent risk factors for distant metastases. Combining assessment of monoclonal antibodies to CD105-positive MVD with assessment of regional lymph node metastasis and tumor size may help to identify patients who need more intensive surveillance after surgery for colorectal cancer.

Indexed as

angiogenesisCD105colorectal cancerdistant metastasismicrovessel density

Identifiers

PMID28599434
PMCPMC5453049
OpenAlexW2602933474

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.